Zealand Pharma to Participate in H.C. Wainwright BIOCONNECT 2022 Conference

2 years ago

Company announcement – No. 1 / 2022 Zealand Pharma to Participate in H.C. Wainwright BIOCONNECT 2022 Conference Copenhagen, DK and Boston, MA, U.S.…

Veru to Present Corporate Update at the H.C. Wainwright BioConnect Conference on January 10-13, 2022

2 years ago

MIAMI, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing…

Acasti Pharma to Present at the H.C. Wainwright BioConnect 2022 Conference

2 years ago

LAVAL, Québec, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST),…

OliX Pharmaceuticals to Participate in BIO Partnering at JPM and Biotech Showcase 2022 Conferences

2 years ago

SUWON, Republic of Korea., Jan. 03, 2022 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi…

Myovant Sciences to Present at the 40th Annual J.P. Morgan Healthcare Conference

2 years ago

BASEL, Switzerland, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women…

Todos Medical to Present at January 5, 2022 Emerging Growth Conference

2 years ago

NEW YORK, NY and TEL AVIV, Israel, Jan. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB:…

The Greenrose Holding Company Closes Asset Purchase of True Harvest, LLC

2 years ago

- True Harvest Expands Greenrose’s Footprint into Arizona and Establishes Strong Cultivation Presence in the Southwest - - Greenrose Provides…

Spero Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Tebipenem HBr for the Treatment of Complicated Urinary Tract Infections including Pyelonephritis

2 years ago

The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of June 27, 2022CAMBRIDGE, Mass., Jan. 03,…

Allarity Therapeutics and Oncoheroes Biosciences Sign Agreements to Advance Pediatric Cancer Development of Dovitinib and Stenoparib

2 years ago

Press release        Oncoheroes will fund and advance the clinical development of both dovitinib and stenoparib in pediatric…

Ortho Clinical Diagnostics to Participate in the 40th Annual J.P. Morgan Healthcare Conference

2 years ago

RARITAN, N.J., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world’s largest…